Abstract
In this journal, Hardwick, Pearse and Petrow (1957) advanced the view that slightly lowered steroidal production may predispose individuals to abnormal mental states, thus suggesting the possibility of treating such disorders with some form of replacement therapy. They screened a number of steroidal compounds for such use and concluded that the most promising was 6β hydroxy:3: 5 cyclopregnan 20-one (“neurosterone”). In their small-scale preliminary study this agent appeared to be of value in the treatment of a variety of psychiatric patients, including those with symptoms of anxiety, depression, and obsessive behaviour.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antiglucocorticoid and related treatments for psychosis;Cochrane Database of Systematic Reviews;2016-01-04
2. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2014-01-06
3. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2007-04-18
4. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2003-04-22
5. Chapter 1. Antipsychotic and Anti-anxiety Agents;Annual Reports in Medicinal Chemistry;1969